XJPX
3101
Market cap952mUSD
Jul 10, Last price
1,727.00JPY
1D
-1.48%
1Q
16.85%
Jan 2017
-0.75%
Name
Toyobo Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Based in Osaka, Japan, Toyobo Co., Ltd. is a global enterprise, established in 1882, that specializes in a broad spectrum of advanced materials and products. Its core operations encompass films, functional polymers, industrial materials, healthcare solutions, and textiles. The company's extensive film portfolio features high-performance industrial films, including PET films specifically engineered for liquid crystal displays, optical applications, and various other industrial uses, along with synthetic papers. For the packaging sector, Toyobo supplies a range of materials such as PET, polyolefin, and nylon films, commonly used for food preservation, as well as heat-shrink PET films. Its functional polymers division offers a comprehensive suite of products, including engineering plastics, industrial adhesives, protective coatings, photo-sensitive printing plates, acrylate polymers, and electronic materials. Additionally, Toyobo is involved in rubber and coat processing and produces intermediates for pharmaceutical manufacturing. In the realm of advanced fibers and textiles, the company develops specialized functional fibers, such as those integrated into airbag fabrics, high-strength polyethylene and PBO fibers, and functional filters designed for automotive, indoor air quality, and anti-pollution solvent adsorption, alongside fiber materials for automobile components. Its textile offerings further include performance fabrics for sports apparel, intimate wear, and uniforms, alongside synthetic filaments. Toyobo also markets branded apparel (Munsingwear), acrylic fibers (Exlan), and acrylate fibers (eks), in addition to engaging in general textile trading. The bio-products segment focuses on healthcare and scientific research, providing enzymes for diagnostic purposes, complete diagnostic systems, and reagents for research. This division also manufactures critical medical components like artificial kidney hollow fibers and anti-clotting materials, alongside modules for seawater desalination. Beyond its diverse manufacturing activities, Toyobo also serves as a contract manufacturer for injectable pharmaceutical products.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||